Boehringer Ingelheim Deal History & Licensing Activity

About Boehringer Ingelheim Licensing & Deal Activity

Boehringer Ingelheim is a large pharma company based in Germany that has been actively engaged in licensing transactions across the biopharma landscape. With 18 deals over the past three years, Boehringer Ingelheim ranks among the most acquisitive companies tracked by Ambrosia Ventures.

Key therapeutic areas of focus for Boehringer Ingelheim include Option Deals (6 deals and trials), Immunology (6 deals and trials), Neurology (5 deals and trials), and Metabolic (5 deals and trials). In terms of modality, Boehringer Ingelheim has shown particular interest in small molecules, other, antibodies.

Ambrosia Ventures tracks deal terms, pipeline data, patent expirations, and competitive positioning for Boehringer Ingelheim and 850+ other biopharma companies. Use our Solidus to benchmark your asset against Boehringer Ingelheim's historical deal terms, or explore all company profiles to find the best partner match for your pipeline.